189 related articles for article (PubMed ID: 29935539)
1. Small size fullerenol nanoparticles suppress lung metastasis of breast cancer cell by disrupting actin dynamics.
Qin Y; Chen K; Gu W; Dong X; Lei R; Chang Y; Bai X; Xia S; Zeng L; Zhang J; Ma S; Li J; Li S; Xing G
J Nanobiotechnology; 2018 Jun; 16(1):54. PubMed ID: 29935539
[TBL] [Abstract][Full Text] [Related]
2. Fullerenol Nanoparticles with Structural Activity Induce Variable Intracellular Actin Filament Morphologies.
Jin J; Dong Y; Wang Y; Xia L; Gu W; Bai X; Chang Y; Zhang M; Chen K; Li J; Zhao L; Xing G
J Biomed Nanotechnol; 2016 Jun; 12(6):1234-44. PubMed ID: 27319217
[TBL] [Abstract][Full Text] [Related]
3. The CT20 peptide causes detachment and death of metastatic breast cancer cells by promoting mitochondrial aggregation and cytoskeletal disruption.
Lee MW; Bassiouni R; Sparrow NA; Iketani A; Boohaker RJ; Moskowitz C; Vishnubhotla P; Khaled AS; Oyer J; Copik A; Fernandez-Valle C; Perez JM; Khaled AR
Cell Death Dis; 2014 May; 5(5):e1249. PubMed ID: 24853427
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the activities of actin-affecting drugs on tumor cell migration.
Hayot C; Debeir O; Van Ham P; Van Damme M; Kiss R; Decaestecker C
Toxicol Appl Pharmacol; 2006 Feb; 211(1):30-40. PubMed ID: 16005926
[TBL] [Abstract][Full Text] [Related]
5. Cytoskeletal Actin Structure in Osteosarcoma Cells Determines Metastatic Phenotype via Regulating Cell Stiffness, Migration, and Transmigration.
Kita K; Asanuma K; Okamoto T; Kawamoto E; Nakamura K; Hagi T; Nakamura T; Shimaoka M; Sudo A
Curr Issues Mol Biol; 2021 Sep; 43(3):1255-1266. PubMed ID: 34698103
[TBL] [Abstract][Full Text] [Related]
6. Hydrophobic interaction mediating self-assembled nanoparticles of succinobucol suppress lung metastasis of breast cancer by inhibition of VCAM-1 expression.
Cao H; Zhang Z; Zhao S; He X; Yu H; Yin Q; Zhang Z; Gu W; Chen L; Li Y
J Control Release; 2015 May; 205():162-71. PubMed ID: 25598420
[TBL] [Abstract][Full Text] [Related]
7. AFM-based study of fullerenol (C60(OH)24)-induced changes of elasticity in living SMCC-7721 cells.
Liu Y; Wang Z; Wang X
J Mech Behav Biomed Mater; 2015 May; 45():65-74. PubMed ID: 25682196
[TBL] [Abstract][Full Text] [Related]
8. Mono-fullerenols modulating cell stiffness by perturbing actin bundling.
Gu W; Bai X; Ren K; Zhao X; Xia S; Zhang J; Qin Y; Lei R; Chen K; Chang YN; Zeng L; Li J; Xing G
Nanoscale; 2018 Jan; 10(4):1750-1758. PubMed ID: 29308471
[TBL] [Abstract][Full Text] [Related]
9. Chrysotobibenzyl inhibition of lung cancer cell migration through Caveolin-1-dependent mediation of the integrin switch and the sensitization of lung cancer cells to cisplatin-mediated apoptosis.
Petpiroon N; Bhummaphan N; Tungsukruthai S; Pinkhien T; Maiuthed A; Sritularak B; Chanvorachote P
Phytomedicine; 2019 May; 58():152888. PubMed ID: 30901662
[TBL] [Abstract][Full Text] [Related]
10. Multiwalled carbon nanotubes inhibit cell migration and invasion by destroying actin cytoskeleton via mitochondrial dysfunction in ovarian cancer cells.
Zhang P; Teng J; Wang L
Aging (Albany NY); 2020 Dec; 12(24):25294-25303. PubMed ID: 33291078
[TBL] [Abstract][Full Text] [Related]
11. PEG-GO@XN nanocomposite suppresses breast cancer metastasis via inhibition of mitochondrial oxidative phosphorylation and blockade of epithelial-to-mesenchymal transition.
Zhang J; Yan L; Wei P; Zhou R; Hua C; Xiao M; Tu Y; Gu Z; Wei T
Eur J Pharmacol; 2021 Mar; 895():173866. PubMed ID: 33454376
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the elastic Young's modulus and cytotoxicity variations in fibroblasts exposed to carbon-based nanomaterials.
Pastrana HF; Cartagena-Rivera AX; Raman A; Ávila A
J Nanobiotechnology; 2019 Feb; 17(1):32. PubMed ID: 30797235
[TBL] [Abstract][Full Text] [Related]
13. Polyisoprenylated cysteinyl amide inhibitors disrupt actin cytoskeleton organization, induce cell rounding and block migration of non-small cell lung cancer.
Ntantie E; Fletcher J; Amissah F; Salako OO; Nkembo AT; Poku RA; Ikpatt FO; Lamango NS
Oncotarget; 2017 May; 8(19):31726-31744. PubMed ID: 28423648
[TBL] [Abstract][Full Text] [Related]
14. The integrin alpha6beta4 functions in carcinoma cell migration on laminin-1 by mediating the formation and stabilization of actin-containing motility structures.
Rabinovitz I; Mercurio AM
J Cell Biol; 1997 Dec; 139(7):1873-84. PubMed ID: 9412479
[TBL] [Abstract][Full Text] [Related]
15. Fullerenol-cytotoxic conjugates for cancer chemotherapy.
Chaudhuri P; Paraskar A; Soni S; Mashelkar RA; Sengupta S
ACS Nano; 2009 Sep; 3(9):2505-14. PubMed ID: 19681636
[TBL] [Abstract][Full Text] [Related]
16. The F-actin bundler SWAP-70 promotes tumor metastasis.
Chang CY; Pearce G; Betaneli V; Kapustsenka T; Hosseini K; Fischer-Friedrich E; Corbeil D; Karbanová J; Taubenberger A; Dahncke B; Rauner M; Furesi G; Perner S; Rost F; Jessberger R
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38760173
[TBL] [Abstract][Full Text] [Related]
17. Ascofuranone suppresses invasion and F-actin cytoskeleton organization in cancer cells by inhibiting the mTOR complex 1 signaling pathway.
Jeong YJ; Hwang SK; Magae J; Chang YC
Cell Oncol (Dordr); 2020 Oct; 43(5):793-805. PubMed ID: 32488849
[TBL] [Abstract][Full Text] [Related]
18. CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.
Wang X; Osada T; Wang Y; Yu L; Sakakura K; Katayama A; McCarthy JB; Brufsky A; Chivukula M; Khoury T; Hsu DS; Barry WT; Lyerly HK; Clay TM; Ferrone S
J Natl Cancer Inst; 2010 Oct; 102(19):1496-512. PubMed ID: 20852124
[TBL] [Abstract][Full Text] [Related]
19. RGD binding to integrin alphavbeta3 affects cell motility and adhesion in primary human breast cancer cultures.
Georgoulis A; Havaki S; Drosos Y; Goutas N; Vlachodimitropoulos D; Aleporou-Marinou V; Kittas C; Marinos E; Kouloukoussa M
Ultrastruct Pathol; 2012 Dec; 36(6):387-99. PubMed ID: 23181508
[TBL] [Abstract][Full Text] [Related]
20. CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.
Hoffmann C; Mao X; Dieterle M; Moreau F; Al Absi A; Steinmetz A; Oudin A; Berchem G; Janji B; Thomas C
Oncotarget; 2016 Mar; 7(12):13688-705. PubMed ID: 26883198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
